NCT07016126
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Guangdong provincial people's hospital Guangzhou, Guangdong, China
Clinical trial condition
NSCLC (Non-small Cell Lung Cancer)
Explore clinical trials studying NSCLC (Non-small Cell Lung Cancer). Study availability and eligibility vary by location and protocol.
59 public trials
38 recruiting studies
NSCLC (Non-small Cell Lung Cancer) trial results
NCT06967532
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Medical University of Vienna Vienna, Austria
NCT06939127
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, China
NCT06617416
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Cancer Hospital of Shandong First Medical University Jinan, China
NCT06863506
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- 2nd Affiliated Hospital, School of Medicine Hangzhou, Zhejiang, China
NCT06684418
- Conditions
- Artificial Intelligence (AI), Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Fudan university Shanghai Cancer Center Shanghai, China
NCT06667167
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Shaare Zedek Medical Center Jerusalem, Israel
Recruiting
Cognitive Screening in Lung Cancer Patients
NCT06727370
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Istituto Europeo di Oncologia Milan, Italy
NCT07814248
- Conditions
- Adnexal Diseases, Bronchial Neoplasms, Carcinoma, +45 more
- Locations
-
Not specified
Not yet recruiting
Neoadjuvant Therapy With Firmonertinib Combined With Anlotinib and Platinum-Based Doublet Chemotherapy for Resectable EGFR-Mutated NSCLC
NCT07807722
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Hubei Cancer Hospital Wuhan, Hubei, China